Estudio retrospectivo, no intervencionista, unicéntrico para describir una cohorte española de pacientes con FMF e identificar pacientes tratados de manera subóptima con mínima actividad de la enfermedad y su impacto en la CVRS (Calidad de vida relacionada con la salud).

Datos básicos

Protocolo:
CACZ885NES01R
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2023
Año de finalización:
2024
ESTUDIO OBSERVACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

NOVARTIS FARMACEUTICA, S.A.

Resultados del Ensayo Clínico


CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)

Torrat Noves, A. M.; (...); Roman Ivorra, J. A.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023


Childhood-Onset Non-Infectious Uveitis in the "Biologic Era". Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings.

Mesa-Del-Castillo P; (...); Sánchez Sevila JL

Article. 10.1080/09273948.2024.2336609. 2024


Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-alpha inhibitor initiation in children in Spain.

Calzada-Hernandez, Joan; (...); Noguera-Julian, Antoni

Article. 10.1007/s00431-022-04640-3. 2022

  • Open Access.

HOW TO DIAGNOSE: JUVENILE PSORIATIC ARTHRITIS. MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY IN CHILDREN WITH SUSPECTED DIAGNOSIS

Palmou-Fontana, N.; (...); Collado, P.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.1883. 2023


INSIGHTS FROM A NOVEL MONOGENIC AUTOIMMUNE DISEASE: OVERVIEW OF A MULTICENTRIC EUROPEAN COHORT OF 27 PATIENTS WITH COPA SYNDROME

David-Gabarre, C.; (...); Fremond, M. L.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3505. 2023


Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.

Brunner, Hermine I; (...); De Benedetti, Fabrizio

Article. 10.1093/rheumatology/keae180. 2024

  • Open Access.

Long-term efficacy/safety of canakinumab in patients with tumor necrosis factor receptor-associated periodic syndrome: results from a phase III trial.

Gattorno, Marco; (...); Lachmann, Helen

Article. 10.1002/art.42695. 2023

  • Open Access.

Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.

Brunner, Hermine I; (...); Ruperto, Nicolino

Article. 10.1002/acr.25156. 2023

  • Open Access.

MUSCULOSKELETAL INVOLVEMENT IMPAIRS QUALITY OF LIFE IN JUVENILE PSORIATIC ARTHRITIS

Collado, P.; (...); Lopez Robledillo, J. C.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.3892. 2023


Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial

Brunner, Hermine; (...); Wilde, Paul

Meeting Abstract. 2023


Real-World Health Care Outcomes and Costs Among Patients With Juvenile Idiopathic Arthritis in Spain.

Antón J; (...); Calvo Penadés I

Article. 10.36469/001c.85088. 2023

  • Open Access.

What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

Murias, Sara; (...); Anton, Jordi

Article. 10.1016/j.reuma.2021.12.003. 2023

  • Open Access.

What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.

Murias, Sara; (...); Anton, Jordi

Article. 10.1016/j.reumae.2022.11.002. 2023


Campos de Estudio

Compartir